文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Research and development of drug delivery systems based on drug transporter and nano-formulation.

作者信息

Peng Yi, Chen Lu, Ye Sheng, Kang Yu, Liu Junqing, Zeng Su, Yu Lushan

机构信息

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.

The Children's Hospital, School of Medicine, Zhejiang University, Hangzhou 310058, China.

出版信息

Asian J Pharm Sci. 2020 Mar;15(2):220-236. doi: 10.1016/j.ajps.2020.02.004. Epub 2020 Mar 4.


DOI:10.1016/j.ajps.2020.02.004
PMID:32373201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7193453/
Abstract

In recent years, the continuous occurrence of multi-drug resistance in the clinic has made people pay more attention to the transporter. Changes in the expression and activity of transporters can cause corresponding changes in drug pharmacokinetics and pharmacodynamics. The drug-drug interactions (DDI) caused by transporters can seriously affect drug effectiveness and toxicity. In the development of pharmaceutical preparations, people have increasingly concerned about the effects and regulation of transporters in drug effects. To improve the targeting and physicochemical properties of drugs, the development of targeted agents is very rapid. Among them, novel nano-formulations are the best. With the continuous innovation and development of nano-formulation, its application has become more and more extensive. Nano-formulation has exerted certain advantages in the drug development based on transporters, and is also involved in the combination of targeted transporters. This review focuses on the application of novel nano-agents targeting transporters and the introduction of drug-transporter-based nano-formulations.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39b0/7193453/063c30d2e777/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39b0/7193453/7dc381948e90/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39b0/7193453/063c30d2e777/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39b0/7193453/7dc381948e90/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39b0/7193453/063c30d2e777/gr1.jpg

相似文献

[1]
Research and development of drug delivery systems based on drug transporter and nano-formulation.

Asian J Pharm Sci. 2020-3

[2]
Emerging transporter-targeted nanoparticulate drug delivery systems.

Acta Pharm Sin B. 2019-1

[3]
Nano-formulations of drugs: Recent developments, impact and challenges.

Biochimie. 2016

[4]
Targeting intestinal transporters for optimizing oral drug absorption.

Curr Drug Metab. 2010-11

[5]
Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects.

Expert Opin Drug Deliv. 2015-7

[6]
Advances in P-glycoprotein-based approaches for delivering anticancer drugs: pharmacokinetic perspective and clinical relevance.

Expert Opin Drug Deliv. 2013-12-3

[7]
Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types.

Front Pharmacol. 2018-1-26

[8]
Interaction of Drug or Food with Drug Transporters in Intestine and Liver.

Curr Drug Metab. 2015

[9]
In vitro comparative evaluation of monolayered multipolymeric films embedded with didanosine-loaded solid lipid nanoparticles: a potential buccal drug delivery system for ARV therapy.

Drug Dev Ind Pharm. 2014-5

[10]
The Effect of Piperine Pro-Nano Lipospheres on Direct Intestinal Phase II Metabolism: The Raloxifene Paradigm of Enhanced Oral Bioavailability.

Mol Pharm. 2018-3-19

引用本文的文献

[1]
The plant matrix of Artemisia annua L. for the treatment of malaria: Pharmacodynamic and pharmacokinetic studies.

PLoS One. 2025-5-7

[2]
Pharmacogenomics influence on MDR1-associated cancer resistance and innovative drug delivery approaches: advancing precision oncology.

Med Oncol. 2025-2-6

[3]
Drug delivery strategies to improve the treatment of corneal disorders.

Heliyon. 2025-1-10

[4]
Emerging role of exosomes in cancer therapy: progress and challenges.

Mol Cancer. 2025-1-13

[5]
Progress in Nanotechnology for Treating Ocular Surface Chemical Injuries: Reflecting on Advances in Ophthalmology.

Adv Sci (Weinh). 2025-2

[6]
Antibiotic-loaded lactoferrin nanoparticles as a platform for enhanced infection therapy through targeted elimination of intracellular bacteria.

Asian J Pharm Sci. 2024-8

[7]
Investigation of pH-dependent Paclitaxel delivery mechanism employing Chitosan-Eudragit bioresponsive nanocarriers: a molecular dynamics simulation.

J Biol Eng. 2024-9-9

[8]
Prenatal opioid exposure significantly impacts placental protein kinase C (PKC) and drug transporters, leading to drug resistance and neonatal opioid withdrawal syndrome.

Front Neurosci. 2024-8-19

[9]
A Patent Analysis on Nano Drug Delivery Systems.

Recent Pat Nanotechnol. 2025

[10]
Bioanalytical HPLC method with fluorescence detector for determination of Entresto™ when co-administered with ibuprofen and fexofenadine: a pharmacokinetic study.

RSC Adv. 2024-6-14

本文引用的文献

[1]
Cilastatin protects against imipenem-induced nephrotoxicity inhibition of renal organic anion transporters (OATs).

Acta Pharm Sin B. 2019-9

[2]
Magnetic cationic liposomal nanocarriers for the efficient drug delivery of a curcumin-based vanadium complex with anticancer potential.

J Inorg Biochem. 2019-7-15

[3]
Tumor-Targeted Dendrimer Nanoparticles for Combinatorial Delivery of siRNA and Chemotherapy for Cancer Treatment.

Methods Mol Biol. 2020

[4]
Formulation optimization of an ephrin A2 targeted immunoliposome encapsulating reversibly modified taxane prodrugs.

J Control Release. 2019-8-7

[5]
Multidrug resistance-associated protein 4 in pharmacology: Overview of its contribution to pharmacokinetics, pharmacodynamics and pharmacogenetics.

Life Sci. 2019-6-7

[6]
Organic anion transporter 3 (OAT3)-mediated transport of dicaffeoylquinic acids and prediction of potential drug-drug interaction.

Eur J Pharm Sci. 2019-3-27

[7]
Cationic liposome codelivering PI3K pathway regulator improves the response of BRCA1-deficient breast cancer cells to PARP1 inhibition.

J Cell Biochem. 2019-3-14

[8]
Nanocrystals: An Overview of Fabrication, Characterization and Therapeutic Applications in Drug Delivery.

Curr Pharm Des. 2018

[9]
Composition design and medical application of liposomes.

Eur J Med Chem. 2019-1-7

[10]
Polyamidoamine dendrimers-based nanomedicine for combination therapy with siRNA and chemotherapeutics to overcome multidrug resistance.

Eur J Pharm Biopharm. 2019-1-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索